US panel wants more data before resuming use of J&J COVID-19 jab | Inquirer News

US panel wants more data before resuming use of J&J COVID-19 jab

/ 06:15 AM April 15, 2021
US panel wants more data before resuming use of J&J COVID-19 jab

FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson& Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration

A U.S. health panel on Wednesday agreed they wanted more data before voting to resume vaccinations with Johnson & Johnson’s COVID-19 shot, even as a U.S. Food and Drug Administration scientist said warnings could mitigate the risk of rare but serious blood clots.

The advisory panel aims to reconvene in a week to 10 days.

ADVERTISEMENT

The panel is reviewing six reported cases of rare brain blood clots in women who received the J&J vaccine, a day after federal regulators paused its use to assess the issue.

Dr. Lynn Batha, an epidemiologist at the Minnesota health department, and several others spoke in favor of extending the pause to gather more safety information.

FEATURED STORIES

“By having more robust information, I think we can be more confident about how we talk about the safety of this vaccine,” she told other members of the U.S. Centers for Disease Control and Prevention (CDC) advisory panel.

Earlier, the FDA’s deputy director for vaccine development, Doran Fink, told the CDC panel that his current thinking was that warning statements and communications from the federal agency would allow doctors to weigh the risks and benefits of the vaccine.

Other panel members, however, expressed concern that extending the pause could worsen issues related to equitable access to the vaccine, which is seen as important for serving hard-to-reach communities because it can be stored in normal refrigerator temperatures and is given as one dose instead of two.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Coronavirus, COVID-19, Health, Janssen, Johnson & Johnson, pandemic, SARS-CoV-2, US, US FDA, vaccine, Virus
For feedback, complaints, or inquiries, contact us.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.



© Copyright 1997-2023 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.